Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Davita Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $25.35 (market cap $141.17B), while Davita Inc trades at $232.01 (market cap $15.12B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 9.3× Davita Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 4.25% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| BBVA | DVA | |
|---|---|---|
Market Cap | $141.17B | $15.12B |
Sector | Financials | Health |
52-Week High | $26.14 | $235.71 |
52-Week Low | $14.73 | $103.87 |
Dividend Yield | 4.25% | — |
Enterprise Value | — | $27.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
